Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 18 |
GO:0031514 | motile cilium | 5 | 18 |
GO:0042995 | cell projection | 2 | 18 |
GO:0043226 | organelle | 2 | 18 |
GO:0043227 | membrane-bounded organelle | 3 | 18 |
GO:0110165 | cellular anatomical entity | 1 | 18 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 18 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4H8L6
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 19 |
GO:0005509 | calcium ion binding | 5 | 19 |
GO:0043167 | ion binding | 2 | 19 |
GO:0043169 | cation binding | 3 | 19 |
GO:0046872 | metal ion binding | 4 | 19 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 195 | 199 | PF00656 | 0.390 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.440 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 145 | 149 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.520 |
DEG_APCC_DBOX_1 | 114 | 122 | PF00400 | 0.384 |
DOC_CKS1_1 | 35 | 40 | PF01111 | 0.517 |
DOC_MAPK_gen_1 | 41 | 48 | PF00069 | 0.545 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.621 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.776 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.539 |
LIG_14-3-3_CanoR_1 | 29 | 33 | PF00244 | 0.560 |
LIG_Actin_WH2_2 | 67 | 84 | PF00022 | 0.473 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.529 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.447 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.587 |
LIG_FHA_2 | 178 | 184 | PF00498 | 0.310 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.321 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.455 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.598 |
LIG_LIR_Gen_1 | 105 | 116 | PF02991 | 0.457 |
LIG_LIR_Gen_1 | 128 | 135 | PF02991 | 0.362 |
LIG_LIR_Gen_1 | 180 | 188 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 105 | 111 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 123 | 127 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 180 | 184 | PF02991 | 0.347 |
LIG_Rb_pABgroove_1 | 125 | 133 | PF01858 | 0.365 |
LIG_SH2_PTP2 | 108 | 111 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.369 |
LIG_SUMO_SIM_anti_2 | 104 | 113 | PF11976 | 0.422 |
LIG_SUMO_SIM_anti_2 | 126 | 133 | PF11976 | 0.356 |
LIG_TRAF2_1 | 60 | 63 | PF00917 | 0.562 |
MOD_CDK_SPxxK_3 | 34 | 41 | PF00069 | 0.528 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.586 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.311 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.358 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.412 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.678 |
MOD_GlcNHglycan | 135 | 139 | PF01048 | 0.398 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.398 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.416 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.374 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.475 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.524 |
MOD_N-GLC_1 | 173 | 178 | PF02516 | 0.398 |
MOD_N-GLC_1 | 3 | 8 | PF02516 | 0.787 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.421 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.386 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.653 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.551 |
MOD_Plk_1 | 125 | 131 | PF00069 | 0.366 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.386 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.530 |
MOD_SPalmitoyl_4 | 1 | 7 | PF01529 | 0.674 |
MOD_SUMO_for_1 | 200 | 203 | PF00179 | 0.412 |
MOD_SUMO_rev_2 | 14 | 24 | PF00179 | 0.514 |
MOD_SUMO_rev_2 | 143 | 150 | PF00179 | 0.395 |
TRG_DiLeu_BaEn_1 | 42 | 47 | PF01217 | 0.361 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.472 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.358 |
TRG_ER_diArg_1 | 33 | 36 | PF00400 | 0.476 |
TRG_Pf-PMV_PEXEL_1 | 82 | 86 | PF00026 | 0.399 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6S0 | Leptomonas seymouri | 64% | 99% |
A0A0S4J8L5 | Bodo saltans | 37% | 100% |
A0A0S4KMR0 | Bodo saltans | 40% | 100% |
A0A1X0NZ95 | Trypanosomatidae | 62% | 99% |
A0A1X0P0A5 | Trypanosomatidae | 59% | 100% |
A0A1X0P0I3 | Trypanosomatidae | 61% | 93% |
A0A3R7KL32 | Trypanosoma rangeli | 61% | 100% |
A0A3S7WTZ3 | Leishmania donovani | 74% | 100% |
A0A422NDP3 | Trypanosoma rangeli | 58% | 99% |
A4H8L5 | Leishmania braziliensis | 97% | 100% |
A4HWY6 | Leishmania infantum | 78% | 100% |
A4HWY7 | Leishmania infantum | 73% | 100% |
C9ZW14 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 93% |
C9ZW16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 87% |
E9AQQ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 67% | 100% |
E9AQQ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 73% | 100% |
P07749 | Trypanosoma cruzi | 56% | 96% |
P17882 | Trypanosoma brucei brucei | 55% | 87% |
Q26677 | Trypanosoma brucei brucei | 57% | 89% |
Q26680 | Trypanosoma brucei brucei | 56% | 93% |
Q27052 | Trypanosoma rangeli | 57% | 100% |
V5D941 | Trypanosoma cruzi | 56% | 82% |